Neostem (NBS) Misses Q3 EPS Views; Revs Light
Tweet
Share
E-mailGet Alerts NBS Hot Sheet
Join SI Premium – FREE
Neostem (AMEX: NBS) reported Q3 loss to controlling interests of ($0.13), $0.02 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $17.8 million versus the consensus estimate of $22.01 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
